Researchers have identified for the first time a defined set of gut bacteria -- cytophaga-flavobacter-bacteroidetes or CFB -- linked to the creation of pro-inflammatory immune or Th17 cells in mice. The researchers say if bacteria can trigger a response, it can be manipulated for treatments for inflammatory bowel disease and other conditions.

Full Story:

Related Summaries